Report Summary
The high and rapidly increasing popularity of social media platforms such as Facebook, YouTube, and Twitter is expected to revolutionize the marketing strategies employed in the pharmaceuticals industry. In addition to marketing, an increasing number of pharma players have also begun leveraging these platforms to enhance consumer relationships and improve brand management, based on the market intelligence generated by monitoring and analyzing user-generated content.
The ability to incorporate consumer feedback to develop new products is also expected to initiate a strategic shift in the operational model of pharma companies. Social media involvements are expected to increase product sales, especially those of OTC drugs, in the long term. Novartis for instance has already begun using Youtube and Facebook to enhance the sales for its OTC drugs such as Comtrax, Orofar and Bufferin. J&J, one of the first pharma giants to enter the social media space, has used online platforms for crisis management - when the company recalled its products (Tylenol and Benadryl tablets) it used social websites to apologize to consumers for irregularities in its manufacturing plant found during FDA inspection.
Market estimates and forecast
The report provides in-depth social media usage in pharmaceutical industry and analyses top 20 pharmaceutical players individually, for their social media presence. Further effective social media strategies are discussed in detail that can be useful in developing a successful social media campaign for pharmaceutical market. Benefits, Risks and Future impact of social media are analyzed separately. Geographic variations in terms of social media usage and regulations are also covered.
Powerful Research and Analysis
MarketsandMarkets (M&M) is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world. MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services.
M&M covers thirteen industry verticals, including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT.
The ability to incorporate consumer feedback to develop new products is also expected to initiate a strategic shift in the operational model of pharma companies. Social media involvements are expected to increase product sales, especially those of OTC drugs, in the long term. Novartis for instance has already begun using Youtube and Facebook to enhance the sales for its OTC drugs such as Comtrax, Orofar and Bufferin. J&J, one of the first pharma giants to enter the social media space, has used online platforms for crisis management - when the company recalled its products (Tylenol and Benadryl tablets) it used social websites to apologize to consumers for irregularities in its manufacturing plant found during FDA inspection.
Market estimates and forecast
The report provides in-depth social media usage in pharmaceutical industry and analyses top 20 pharmaceutical players individually, for their social media presence. Further effective social media strategies are discussed in detail that can be useful in developing a successful social media campaign for pharmaceutical market. Benefits, Risks and Future impact of social media are analyzed separately. Geographic variations in terms of social media usage and regulations are also covered.
Powerful Research and Analysis
MarketsandMarkets (M&M) is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world. MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services.
M&M covers thirteen industry verticals, including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT.
Table of Contents
Executive Summary
Social Media Overview
Key Social Media Tools
Effective Social Media Strategies
Benefit & Risk Analysis Of Social Media In Healthcare
Impact Of Social Media On Healthcare Stakeholders
Geographic Analysis Of Use Of Social Media
Future Impact Of Social Media
Case Studies Of Top 20 Pharmaceutical Companies
1 Introduction
1.1 Key Take-aways
1.2 Report Description
1.3 Scope And Format
1.4 Stakeholders
1.5 Research Methodology
2 Social Media Overview
2.1 Introduction
2.2 Drivers And Restraints Of Socail Media Use In Pharmaceutical Industry
2.3 Conventional Media Vs. Online Social Media
2.4 Role Of Internet In Healthcare
2.4.1 Web 1.0 To Web 2.0
2.4.2 Web 2.0 & Health 2.0
2.5 Social Media Evolution In Healthcare
2.5.1 Social Media: A Strategic Shift In Communication Choices
2.6 Use Of Social Media By Top Pharmaceutical Players
2.7 Social Media Strategies Used By Top Pharmaceutical Players
3 Key Social Media Tools
3.1 Introduction
3.2 Types Of Social Media Tools
3.2.1 Twitter
3.2.2 Facebook
3.2.3 Youtube
3.2.4 Blogs
3.2.5 Condition-specific Communities
3.2.6 Other Social Media Tools
3.3 Comparative Analysis
4 Effective Social Media Strategies
4.1 Introduction
4.2 Determine The Right Social Media Mix
4.2.1 Define Goals & Target Audience
4.2.2 Effective Listening & Monitoring
4.2.3 Use Multiple Tools
4.3 Enlarge User-base/Online Audience
4.3.1 Generate Traffic On Social Media
4.3.2 Trigger Conversations To Explore Business Opportunities
4.4 Develop Brand Perception
4.4.1 Integrate Offline & Online Campaigns
4.4.2 Build Consumer Engagement & Trust
4.4.3 Online Video Distribution
4.5 Building Consumer Communities
4.5.1 Create/Sponsor Collaborative Tools
4.5.2 Increase Transparency & Respond To Criticism
4.6 Integrate Consumer In The Business
4.6.1 Involvement In Product Testing
4.6.2 Respond To Consumer Needs/Issues
4.7 Polices On Communicating Via Social Platforms
4.7.1 Determine The Right Speakers
4.7.2 Post Relevant Content
4.7.3 Balancing Engagement With Promotion
5 Benefit & Risk Analysis Of Social Media In Healthcare
5.1 Benefit Analysis
5.1.1 Marketing And Sales
5.1.1.1 Business Exposure And Generation
5.1.2 Consumer Relationship Management
5.1.2.1 Public Relations
5.1.2.2 Consumer Feedback And Satisfaction
5.1.3 Treatment And Rx Decisions
5.1.4 Other Benefits
5.1.4.1 Recruitment For Clinical Trials
5.1.4.2 Enhancing Health Awareness
5.1.4.3 Criticism/Crisis Management
5.2 Risk Analysis
5.2.1 Intellectual Property Concerns
5.2.2 Privacy And Security Issues
5.2.3 Accountability/Content Validation
5.2.4 Regulatory Risk Management
6 Impact Of Social Media On Healthcare Stakeholders
6.1 Introduction
6.2 Pharmaceutical/Lifescience Companies
6.3 Hospitals
6.4 Health-related Government Bodies
6.5 Healthcare Professionals
6.6 Patients/Consumers
6.7 Health Insurance Providers
7 Geographic Analysis Of Use Of Social Media
7.1 Introduction
7.1.1 Total Number Of Internet Users And Infrastructure
7.1.2 Social Media Traffic
7.1.3 Regulatory Environment For Social Media Usage
8 Future Impact Of Social Media
8.1 Introduction
8.2 Increase In Social Engagement Of Pharmaceutical Companies
8.3 Consumer Engagement In Business Development
8.4 Reinvention Of Marketing And Sales Strategies
8.5 Innovation In Products And Services
8.6 Support To Sales Force
8.7 Enhance Business Operational Efficiencies
9 Case Studies Of Top 20 Pharmaceutical Companies
9.1 Introduction
9.1.1 Abbott Labs
9.1.2 Amgen
9.1.3 Astellas Pharmaceuticals
9.1.4 Astra-zeneca
9.1.5 Bayer Pharmaceuticals
9.1.6 Baxter
9.1.7 Boehringer Ingelheim
9.1.8 Bristol Myers Squibb
9.1.9 Daiichi Sankyo
9.1.10 Eli Lilly
9.1.11 Glaxosmithkline
9.1.12 Johnson & Johnson
9.1.13 Merck
9.1.14 Novartis
9.1.15 Novo Nordisk
9.1.16 Pfizer
9.1.17 Roche
9.1.18 Sanofi-aventis
9.1.19 Teva Pharmaceuticals
9.1.20 Ucb
Executive Summary
Social Media Overview
Key Social Media Tools
Effective Social Media Strategies
Benefit & Risk Analysis Of Social Media In Healthcare
Impact Of Social Media On Healthcare Stakeholders
Geographic Analysis Of Use Of Social Media
Future Impact Of Social Media
Case Studies Of Top 20 Pharmaceutical Companies
1 Introduction
1.1 Key Take-aways
1.2 Report Description
1.3 Scope And Format
1.4 Stakeholders
1.5 Research Methodology
2 Social Media Overview
2.1 Introduction
2.2 Drivers And Restraints Of Socail Media Use In Pharmaceutical Industry
2.3 Conventional Media Vs. Online Social Media
2.4 Role Of Internet In Healthcare
2.4.1 Web 1.0 To Web 2.0
2.4.2 Web 2.0 & Health 2.0
2.5 Social Media Evolution In Healthcare
2.5.1 Social Media: A Strategic Shift In Communication Choices
2.6 Use Of Social Media By Top Pharmaceutical Players
2.7 Social Media Strategies Used By Top Pharmaceutical Players
3 Key Social Media Tools
3.1 Introduction
3.2 Types Of Social Media Tools
3.2.1 Twitter
3.2.2 Facebook
3.2.3 Youtube
3.2.4 Blogs
3.2.5 Condition-specific Communities
3.2.6 Other Social Media Tools
3.3 Comparative Analysis
4 Effective Social Media Strategies
4.1 Introduction
4.2 Determine The Right Social Media Mix
4.2.1 Define Goals & Target Audience
4.2.2 Effective Listening & Monitoring
4.2.3 Use Multiple Tools
4.3 Enlarge User-base/Online Audience
4.3.1 Generate Traffic On Social Media
4.3.2 Trigger Conversations To Explore Business Opportunities
4.4 Develop Brand Perception
4.4.1 Integrate Offline & Online Campaigns
4.4.2 Build Consumer Engagement & Trust
4.4.3 Online Video Distribution
4.5 Building Consumer Communities
4.5.1 Create/Sponsor Collaborative Tools
4.5.2 Increase Transparency & Respond To Criticism
4.6 Integrate Consumer In The Business
4.6.1 Involvement In Product Testing
4.6.2 Respond To Consumer Needs/Issues
4.7 Polices On Communicating Via Social Platforms
4.7.1 Determine The Right Speakers
4.7.2 Post Relevant Content
4.7.3 Balancing Engagement With Promotion
5 Benefit & Risk Analysis Of Social Media In Healthcare
5.1 Benefit Analysis
5.1.1 Marketing And Sales
5.1.1.1 Business Exposure And Generation
5.1.2 Consumer Relationship Management
5.1.2.1 Public Relations
5.1.2.2 Consumer Feedback And Satisfaction
5.1.3 Treatment And Rx Decisions
5.1.4 Other Benefits
5.1.4.1 Recruitment For Clinical Trials
5.1.4.2 Enhancing Health Awareness
5.1.4.3 Criticism/Crisis Management
5.2 Risk Analysis
5.2.1 Intellectual Property Concerns
5.2.2 Privacy And Security Issues
5.2.3 Accountability/Content Validation
5.2.4 Regulatory Risk Management
6 Impact Of Social Media On Healthcare Stakeholders
6.1 Introduction
6.2 Pharmaceutical/Lifescience Companies
6.3 Hospitals
6.4 Health-related Government Bodies
6.5 Healthcare Professionals
6.6 Patients/Consumers
6.7 Health Insurance Providers
7 Geographic Analysis Of Use Of Social Media
7.1 Introduction
7.1.1 Total Number Of Internet Users And Infrastructure
7.1.2 Social Media Traffic
7.1.3 Regulatory Environment For Social Media Usage
8 Future Impact Of Social Media
8.1 Introduction
8.2 Increase In Social Engagement Of Pharmaceutical Companies
8.3 Consumer Engagement In Business Development
8.4 Reinvention Of Marketing And Sales Strategies
8.5 Innovation In Products And Services
8.6 Support To Sales Force
8.7 Enhance Business Operational Efficiencies
9 Case Studies Of Top 20 Pharmaceutical Companies
9.1 Introduction
9.1.1 Abbott Labs
9.1.2 Amgen
9.1.3 Astellas Pharmaceuticals
9.1.4 Astra-zeneca
9.1.5 Bayer Pharmaceuticals
9.1.6 Baxter
9.1.7 Boehringer Ingelheim
9.1.8 Bristol Myers Squibb
9.1.9 Daiichi Sankyo
9.1.10 Eli Lilly
9.1.11 Glaxosmithkline
9.1.12 Johnson & Johnson
9.1.13 Merck
9.1.14 Novartis
9.1.15 Novo Nordisk
9.1.16 Pfizer
9.1.17 Roche
9.1.18 Sanofi-aventis
9.1.19 Teva Pharmaceuticals
9.1.20 Ucb
About Us
ReportsandReports comprises an online library of 10,000 reports, in-depth market research studies of over 5000 micro markets, and 25 industry specific websites. Our client list boasts almost all well-known publishers of such reports across the globe. We as a third-party reseller of market research reports employ a number of marketing tools, such as press releases, email-marketing and effective search-engine optimization techniques to drive revenues for our clients. We also provide 24/7 online and offline support service to our customers.
Contact:
Ms. Sunita
7557 Rambler road,
Suite 727, Dallas, TX 75231
Tel: +1-888-989-8004
Original Source: Pharmaceutical Market
